Additionally, the combination of HNF1B expression and CD4+ T cell infiltration levels showed prognostic value in cervical squamous cell carcinoma (CESC), brain lower grade glioma (LGG), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), sarcoma (SARC) (Figure 6B). This evidence concerns the gene HNF1B and cervical squamous cell carcinoma.